glp-1 analog drugs Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Comparing Ozempic, Wegovy and Other

The clinical respiratory journal 2021;15:847 50

First the basics : Weight loss drugs are not new

It compounds existing trends: GLP-1 adoption reinforces several existing shifts: Fewer social drinking occasions Growth in non-alcoholic alternatives Increased health awareness It changes behaviornot just preference: Most alcohol industry changes are substitution-based

C., Bassock, S., Dwyer, A., Engels, E., Qvist, M., Sparre, T., & Snitker, S

Many patients appreciate the low cost of metformin. GLP-1 medications can be expensive, difficult to get insurance coverage for, and may be difficult to find because of ongoing shortages

The mechanism of satiety: effect of glucagon on gastric hunger contractions in man